PRESCRIBING · PART D · 2024
Total Rx claims
227
Beneficiaries
—
Total drug cost
$2.0M
Distinct drugs
4
Brand share
72.2%
Top prescribed drugs
QUALITY · MIPS · 2024
Final MIPS score
83.3
Quality
73.9
Cost
70.5
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.35%
Group
CROSS-REFERENCE